Atlas Trials

BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy

Clinical trial NCT06769555 · WITHDRAWN

Trial details

NCT number
NCT06769555
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
AL Amyloidosis
Start date
2025-01-01
Primary completion
2026-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.